Prevalence of malignant hyperthermia diagnosis in obstetric patients in the United States, 2003 to 2014

BACKGROUND: The cost-benefit of stocking dantrolene in maternity units for treating malignant hyperthermia (MH) has been recently questioned because of the low incidence of MH crisis in the general population and the low utilization of general anesthesia in obstetrics. However, no study has examined...

Descripción completa

Detalles Bibliográficos
Autores principales: Guglielminotti, Jean, Rosenberg, Henry, Li, Guohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971943/
https://www.ncbi.nlm.nih.gov/pubmed/31959119
http://dx.doi.org/10.1186/s12871-020-0934-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971943/
https://www.ncbi.nlm.nih.gov/pubmed/31959119
http://dx.doi.org/10.1186/s12871-020-0934-0

Ejemplares similares